| View |
|
DRP-4549-05
|
Cotrimoxazole
|
Cotripel
|
960 mg
|
Tablet
|
Antibacterial (Sulfonamide)
|
Azarias Pharmaceutical Laboratories Inc.
|
Philippines
|
CLIDP Conversion
|
25 April 2024
|
26 July 2028
|
| View |
|
DRP-4650-01
|
Ursodeoxycholic Acid
|
Destone
|
300 mg
|
Tablet
|
Bile Acid Derivative
|
Sydler Remedies Private Limited
|
India
|
CLIDP Conversion
|
27 April 2024
|
19 December 2025
|
| View |
|
DRP-4809-03
|
Salbutamol (as Sulfate) + Ipratropium Bromide
|
Pulmodual MDI
|
100 mcg / 20 mcg per Actuation
|
Metered Dose Inhaler
|
Bronchodilator
|
Midas-Care Pharmaceuticals, Pvt. Ltd
|
India
|
CLIDP Conversion
|
26 April 2024
|
28 June 2027
|
| View |
|
DRP-4839-11
|
Fenofibrate
|
Fenomel
|
160 mg
|
Capsule
|
Lipid Modifying Agent (Fibrates)
|
Azarias Pharmaceutical Laboratories Inc
|
Philippines
|
CLIDP Conversion
|
27 April 2024
|
16 October 2028
|
| View |
|
DRP-5121-13
|
Cefixime (as trihydrate)
|
Taxim-O
|
200 mg
|
Film-Coated Tablet
|
Antibacterial (Third Generation Cephalosporin)
|
Scott-Edil Advance Research Laboratories & Education Limited
|
India
|
CLIDP Conversion
|
07 April 2024
|
14 October 2028
|
| View |
|
DRP-5121-14
|
Cefixime (as trihydrate)
|
TGXIME
|
200 mg
|
Film-Coated Tablet
|
Antibacterial (Third Generation Cepahlosporin)
|
Scott-Edil Advance Research Laboratories & Education Limited
|
India
|
CLIDP Conversion
|
24 April 2024
|
14 October 2028
|
| View |
|
DRP-523-05
|
Ferrous Sulfate
|
Felizen
|
500 mg (equivalent to 161 mg elemental iron)
|
Capsule
|
Mineral
|
Compact Pharmaceuticals, Corp.
|
Philippines
|
CLIDP Conversion
|
27 April 2024
|
08 October 2028
|
| View |
|
DRP-5272-03
|
Tamsulosin Hydrochloride
|
Tamzor
|
200 mcg
|
Prolonged Release Capsule
|
Alpha-adrenoreceptor Antagonist
|
Stallion Laboratories Pvt. Ltd.
|
India
|
CLIDP Conversion
|
24 April 2024
|
22 April 2029
|
| View |
|
DRP-12544
|
Azithromycin(As Dihydrate)
|
Novazith
|
500 mg
|
Film Coated Tablet
|
Antibacterial (Macrolide)
|
AMN Life Pvt. Ltd.
|
India
|
Initial
|
31 August 2022
|
31 August 2027
|
| View |
|
DRP-5367-10
|
Cefuroxime (as Axetil)
|
Titacef DS
|
250 mg/5 mL
|
Powder for Oral Suspension
|
Antibacterial
|
Zim Laboratories Ltd.
|
India
|
CLIDP Conversion
|
07 April 2024
|
30 June 2029
|
| View |
|
DRP-5367-11
|
Cefuroxime (as Axetil)
|
Pediacef
|
250 mg / 5 mL
|
Powder for Oral Suspension
|
Antibacterial
|
Zim Laboratories Limited
|
India
|
CLIDP Conversion
|
28 April 2024
|
30 June 2029
|
| View |
|
DRP-5403-19
|
Azithromycin (as dihydrate)
|
Ztab 500
|
500 mg
|
Film-Coated Tablet
|
Antibacterial (Macrolide)
|
Magbro Healthcare Pvt. Ltd.
|
India
|
Renewal
|
11 June 2024
|
23 July 2029
|
| View |
|
DRP-5403-20
|
Azithromycin (as dihydrate)
|
Zithrotech
|
500 mg
|
Film-Coated Tablet
|
Antibacterial (Macrolide)
|
Magbro Healthcare Pvt. Ltd
|
India
|
Renewal
|
23 June 2024
|
23 July 2029
|
| View |
|
DRP-5442-04
|
Ampicillin (as sodium) + Sulbactam (as sodium)
|
None
|
500 mg / 250 mg
|
Powder for Injection (IM/IV)
|
Antibacterial (Combination of Penicillin and Beta lactamase Inhibitor)
|
Shin Poong Pharmaceutical Co., Ltd
|
Korea
|
CLIDP Conversion
|
27 April 2024
|
31 May 2027
|
| View |
|
DRP-5600-09
|
Cefoxitin (as Sodium)
|
Brofoxin
|
1 g
|
Powder for Injection (IM/IV)
|
Antibacterial
|
Union Korea Pharm. Co., Ltd.
|
Korea
|
CLIDP Conversion
|
18 April 2024
|
15 October 2029
|
| View |
|
DRP-5685-12
|
Amlodipine (as Besilate) + Losartan Potassium
|
Amlocare Plus
|
5 mg / 50 mg
|
Film-Coated Tablet
|
Calcium Channel Blocker/Angiotensin II Receptor Blocker
|
Lloyd Laboratories, Inc.
|
Philippines
|
Renewal
|
23 June 2024
|
28 October 2029
|
| View |
|
DRP-5754-12
|
Cetirizine Dihydrochloride
|
Citicure
|
2.5 mg/mL
|
Suspension (Oral Drops) (Lemon Flavor)
|
H1-Receptor Antagonist
|
J.M. TOLMANN LABORATORIES INC.
|
Philippines
|
CLIDP Conversion
|
19 April 2024
|
12 March 2029
|
| View |
|
DRP-5834-08
|
Ceftriaxone (as sodium)
|
Gifixon
|
1 g
|
Powder for Injection (I.M./I.V.)
|
Antibacterial (Cephalosporin)
|
Kyung Dong Pharm Co., Ltd.
|
Korea
|
CLIDP Conversion
|
26 April 2024
|
12 September 2028
|
| View |
|
DRP-5926-10
|
Cefixime (as Trihydrate)
|
Shefix
|
100 mg / 5 mL
|
Powder for Suspension
|
Antibacterial (Cephalosporin)
|
Opal Laboratories (Pvt.) Limited
|
Pakistan
|
CLIDP Conversion
|
28 April 2024
|
12 October 2026
|
| View |
|
DRP-5966-12
|
Co-Amoxiclav
|
Clavxytin
|
457 mg/5 mL
|
Powder for Suspension
|
Antibacterial (Combination of penicillin and beta-lactamase inhibitor)
|
Giyaan Pharma Private Limited
|
India
|
CLIDP Conversion
|
16 April 2024
|
27 January 2030
|